Nevisense electrical impedance spectroscopy

DEVICE2 trials

Sponsors

Memorial Sloan Kettering Cancer Center, Castle Biosciences Incorporated

Conditions

Atopic DermatitisLarge Acquired NeviMultiple NeviNevusSkin Lesion

Unknown Phase

Study of the Nevisense Device to Assess Atypical Skin Lesions

CompletedNCT04705168

Memorial Sloan Kettering Cancer CenterLarge Acquired Nevi, Multiple Nevi, Nevus +1

Start: 2021-01-08End: 2025-11-18Updated: 2025-11-20

Evaluation of a Non-Invasive Device for Early Detection of Atopic Dermatitis Flares

RecruitingNCT07645820

Castle Biosciences IncorporatedAtopic Dermatitis

Start: 2026-06-04End: 2027-12-31Target: 450Updated: 2026-09-15